ADTRALZA
Google image searchProduct monograph
Active ingredient
tralokinumab, 150 MG/ML
DIN: 02521288
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PREFILLED SYRINGES
Schedule: Prescription / Schedule D
Company: LEO PHARMA INC
Date: 17-MAR-2022
ATC:
- D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
- D11AH — Agents for atopic dermatitis, excluding corticosteroides (ATC, ATC/DDD)
- D11AH07 — TRALOKINUMAB (ATC/DDD)
Reference brand drug: Adtralza
